Wider use of statins is a “no-brainer”
This article was originally published in Scrip
Executive Summary
A few weeks ago NICE, the health technology body for England and Wales, issued new draft guidance on the use of statins in people considered to be at relatively low risk of cardiovascular diseases such as heart disease, stroke and peripheral arterial disease (scripintelligence.com, 13 February 2014). NICE is recommending that the threshold for starting preventive treatment of these conditions should be halved from a 20% risk of developing CVD over 10 years to a 10% risk.